Bharat Biotech's COVID-19 vaccine 'Covaxin' commences phase-3 trial at AIIMS
The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday.
M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received the first dose of Covaxin. Around 15,000 volunteers at AIIMS will be given the shot as...